Abstract
Regulatory T cells participate in several immune responses including autoimmune reactions inducing selftolerance, tumor immunity, transplantation tolerance and microbial infection. Nevertheless, regulatory T cells actions seem to be different when they are in the central nervous system (CNS), since they interact with resident cells of the CNS, according to the particular conditions elicited in this compartment. This review focuses on the role of regulatory T cells in health, autoimmune and other CNS diseases, pointing out their interactions with resident CNS cells.
Keywords: Brain tumor, central nervous system, cerebral vascular diseases, experimental autoimmune encephalomyelitis, multiple sclerosis, neuroinflammation, regulatory T cells, central nervous system (CNS), glucocorticoid-induced TNF receptor (GITR), antigen presenting cells (APC), Tr1 Regulatory Cells, neurodegenerative disorders, antiproliferative action, experimental autoimmune encephalomyelitis (EAE), autoimmune encephalomyelitis, acetylcholine, glutamate, serotonin, vascular disease, microglia activation, brain tumors, glioblastoma multiforme, heme oxygenase-1 (HO-1), neoangiogenesis, cerebral malaria (ECM), Cytotoxic T lymphocyte-associated antigen 4, Glucocorticoid-induced TNF receptor, Major histocompatibility complex class II
Central Nervous System Agents in Medicinal Chemistry
Title: Regulatory T Cells in Central Nervous System: in Health and Disease
Volume: 10 Issue: 4
Author(s): Brenda Saenz, Jesus Perez-H and Anahi Chavarria
Affiliation:
Keywords: Brain tumor, central nervous system, cerebral vascular diseases, experimental autoimmune encephalomyelitis, multiple sclerosis, neuroinflammation, regulatory T cells, central nervous system (CNS), glucocorticoid-induced TNF receptor (GITR), antigen presenting cells (APC), Tr1 Regulatory Cells, neurodegenerative disorders, antiproliferative action, experimental autoimmune encephalomyelitis (EAE), autoimmune encephalomyelitis, acetylcholine, glutamate, serotonin, vascular disease, microglia activation, brain tumors, glioblastoma multiforme, heme oxygenase-1 (HO-1), neoangiogenesis, cerebral malaria (ECM), Cytotoxic T lymphocyte-associated antigen 4, Glucocorticoid-induced TNF receptor, Major histocompatibility complex class II
Abstract: Regulatory T cells participate in several immune responses including autoimmune reactions inducing selftolerance, tumor immunity, transplantation tolerance and microbial infection. Nevertheless, regulatory T cells actions seem to be different when they are in the central nervous system (CNS), since they interact with resident cells of the CNS, according to the particular conditions elicited in this compartment. This review focuses on the role of regulatory T cells in health, autoimmune and other CNS diseases, pointing out their interactions with resident CNS cells.
Export Options
About this article
Cite this article as:
Saenz Brenda, Perez-H Jesus and Chavarria Anahi, Regulatory T Cells in Central Nervous System: in Health and Disease, Central Nervous System Agents in Medicinal Chemistry 2010; 10 (4) . https://dx.doi.org/10.2174/187152410793429674
DOI https://dx.doi.org/10.2174/187152410793429674 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Monoaminergic Tripartite Synapse: A Putative Target for Currently Available Antidepressant Drugs
Current Drug Targets Cyclooxygenase-2 (COX-2) Mediates Arsenite Inhibition of UVB-Induced Cellular Apoptosis in Mouse Epidermal Cl41 Cells
Current Cancer Drug Targets Glioma Dynamics and Computational Models: A Review of Segmentation, Registration, and In Silico Growth Algorithms and their Clinical Applications
Current Medical Imaging MicroRNAs and Cancer; an Overview
Current Pharmaceutical Biotechnology PHB in Cardiovascular and Other Diseases: Present Knowledge and Implications
Current Drug Targets MicroRNAs in Neuroblastoma: Biomarkers with Therapeutic Potential
Current Medicinal Chemistry Advances of Bioinformatics Applied to Development and Evaluation of Boron-Containing Compounds
Current Organic Chemistry Thirty Years of Polyamine-Related Approaches to Cancer Therapy. Retrospect and Prospect. Part 2. Structural Analogues and Derivatives
Current Drug Targets Status Epilepticus in the Immature Rodent Brain Alters the Dynamics of Autophagy
Current Neurovascular Research Targeting ErbB Receptors in High-Grade Glioma
Current Pharmaceutical Design A Review of Various Machine Learning Techniques for Brain Tumor Detection from MRI Images
Current Medical Imaging Multidisciplinary Cancer Therapy with Telomerase-Specific Oncolytic Adenovirus
Current Cancer Therapy Reviews Merging Transport Data for Choroid Plexus with Blood-Brain Barrier to Model CNS Homeostasis and Disease More Effectively
CNS & Neurological Disorders - Drug Targets Gynaecological Cancer Diagnostics: 99mTc-Cisplatin Complex as a Future Approach for Early, Prompt and Efficient Diagnosis of Gynaecological Cancer
Current Medical Imaging Studies on Non-synonymous Polymorphisms Altering Human DNA Topoisomerase II-Alpha Interaction with Amsacrine and Mitoxantrone: An <i>In Silico</i> Approach
Current Cancer Drug Targets Application of Glutathione as Anti-Oxidative and Anti-Aging Drugs
Current Drug Metabolism Epithelial Mesenchymal Transition in Cancer Progression: Prev entive Phytochemicals
Recent Patents on Anti-Cancer Drug Discovery Arsenic Trioxide Exerts Anti-lung Cancer Activity by Inhibiting Angiogenesis
Current Cancer Drug Targets Recent Advances on Glioblastoma Multiforme and Nano-drug Carriers: A Review
Current Medicinal Chemistry Nanoparticle-based Cerebral Drug-Delivery Systems and Antiangiogenic Approach in Gliomas Treatment
Recent Patents on Nanotechnology